5407972025-04-012025-06-305407972025-06-305407972025-04-012025-06-30in-capmkt:OtherExpenses1Member5407972025-04-012025-06-30in-capmkt:OtherExpenses2Member5407972025-04-012025-06-30in-capmkt:ReportableSegments1Member5407972025-04-012025-06-30in-capmkt:ReportableSegments2Member5407972025-04-012025-06-30in-capmkt:ReportableSegments1Member5407972025-04-012025-06-30in-capmkt:ReportableSegments2Member5407972025-04-012025-06-30in-capmkt:ReportableSegments1Member5407972025-06-30in-capmkt:ReportableSegments1Member5407972025-04-012025-06-30in-capmkt:ReportableSegments2Member5407972025-06-30in-capmkt:ReportableSegments2Member5407972025-04-012025-06-30in-capmkt:ReportableSegments1Member5407972025-06-30in-capmkt:ReportableSegments1Member5407972025-04-012025-06-30in-capmkt:ReportableSegments2Member5407972025-06-30in-capmkt:ReportableSegments2Member5407972025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15407972025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares540797SHALBYNOTLISTEDINE597J01018SHALBY LIMITEDMain BoardEquity2025-04-012026-03-312025-08-132025-08-05INRMillionsQuarterlyFirst quarterMulti segment2025-08-1315:00:002025-08-1315:57:00Not applicable2025-04-012025-06-30UnauditedConsolidated2964260000700800003034340000154570000293410000-6600000046509000093710000165230000170180000028078100002265300000226530000183440000-33690000149750000076780000000076780000-45900007219000089200000-124400004580000-100001074870000100.710.71000.710.711. The unaudited consolidated financial results for the quarter ended June 30, 2025 have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the company at their respective meetings held on August 13, 2025. The Statutory Auditors of the Company have carried out a Limited Review for said unaudited financial results. <BR> <BR> 2. These financial results have been prepared in accordance with Indian Accounting Standards Ind AS as prescribed under section 133 of Companies Act 2013 read with Rule 3 of the Companies Indian Accounting Standards Rules 2015 and relevant amendment thereafter. <BR> <BR> 3. The figures for quarter ended March 31, 2025 are the balancing figures between the audited figures in respect of the full financial year and the reviewed year-to-date figures up to the third quarter of the respective financial year. <BR> <BR> 4. Shalby Limited Employees Welfare Trust has acquired 7,00,000 Equity Shares of Shalby Limited in June 2022 through market purchase pursuant to Employee Stock Option Scheme-2021. Till June 30, 2025, Company has granted all 7,00,000 Stock Options to eligible employees, out of which total 3,19,765 Stock Options were lapsed and 1,77,235 Options were vested and exercised by eligible employees. <BR> <BR> In accordance with the resolution passed by the Nomination and Remuneration Committee, the Company has granted 15,000 stock options from the pool of 3,19,765 lapsed options and as of June 30, 2025, a total of 2,18,000 stock options remain active. <BR> <BR> 5. The consolidated financial result includes the results of the Company and 14 Subsidiary companies Covering 4 stepdown subsidiaies. The company together with its subsidiaries is herein referred to as the Group. <BR> <BR> 6. The Group is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI HO DDHS CIR P 2018 144 dated November 26, 2018. <BR> <BR> 7. The Code on Social Security, 2020 Code relating to employee benefits during employment and post employment benefits has received Presidential assent and has been published in the Gazette of India. However, the effective date of the Code and final rules for quantifying the financial impact are yet to be notified. The Group will assess the impact of the Code when relevant provisions are notified and will record related impact, if any, in the period the Code becomes effective. <BR> <BR> 8. As per Indian Accounting Standard Ind AS 108 - Segment Reporting, segment information has been provided in Consolidated Financial Results. The business segments of the company comprise of Healthcare Activities & Manufacturing of Implant. Disclosure for the same is given in the separate note attached herewith in Annexure I. <BR> <BR> 9. Previous period figures have been re-grouped, re-cast and re-arranged wherever considered necessary to make it comparable.Other Expenses295160000Operating Expenses1406640000Healthcare Services2683630000Manufacturing of Implants280630000296426000002964260000Healthcare Services325670000Manufacturing of Implants-9914000022653000000226530000Healthcare Services12872150000Manufacturing of Implants486880000017740950000017740950000Healthcare Services4493530000Manufacturing of Implants3238450000773198000007731980000Items that will not be reclassified to profit & Loss780000780000270000items that will be reclassified to profit or loss-5100000-51000000-4590000